Concepedia

Publication | Open Access

Nine-week trastuzumab treatment versus 52-week trastuzumab treatment for HER2-positive early-stage breast cancer

DOIFull Paper Access

14

Citations

19

References

2012

Year

Önder Tonyalı, Uğur Çoşkun, Nur Şener, Mevlüde İnanç, Tülay Akman, Berna Öksüzoğlu, Nuriye Özdemir, Mustafa Beneklı, Aytuğ Üner, Deniz Yamaç,
Journal of Cancer Research and Clinical Oncology

References

YearCitations

Page 1